These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7537525

  • 41. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
    Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L.
    Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 45. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS, Hughes NK, Hulette BC, Noblitt L.
    J Leukoc Biol; 1991 Dec 15; 50(6):580-6. PubMed ID: 1940611
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Diminished erythropoietin-induced erythroid growth in patients with renal anemia is restored by recombinant human erythroid differentiation factor.
    Shimizu T, Kawano Y, Takaue Y, Kuroda Y.
    Am J Hematol; 1994 Nov 15; 47(3):178-82. PubMed ID: 7942781
    [Abstract] [Full Text] [Related]

  • 48. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions.
    Zauli G, Vitale M, Visani G, Marchisio M, Milani D, Capitani S.
    Br J Haematol; 1994 Mar 15; 86(3):461-7. PubMed ID: 7519034
    [Abstract] [Full Text] [Related]

  • 49. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb 15; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 50. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Feb 15; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 51. Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice.
    Leigh BR, Webb S, Hancock SL, Knox SJ.
    Stem Cells; 1994 Jul 15; 12(4):430-5. PubMed ID: 7524895
    [Abstract] [Full Text] [Related]

  • 52. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
    Pharr PN, Hankins D, Hofbauer A, Lodish HF, Longmore GD.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):938-42. PubMed ID: 7679218
    [Abstract] [Full Text] [Related]

  • 53. IL-3 increases marrow and peripheral erythroid precursors in chronic pure red cell aplasia presenting in childhood.
    Bastion Y, Campos L, Roubi N, Bienvenu J, Felman P, Dumontet C, Coiffier B.
    Br J Haematol; 1995 Feb 01; 89(2):413-6. PubMed ID: 7873394
    [Abstract] [Full Text] [Related]

  • 54. In vitro CFU-E and BFU-E responses to androgen in bone marrow from children with primary hypoproliferative anaemia: a possible therapeutic assay.
    Claustres M, Margueritte G, Sultan C.
    Eur J Pediatr; 1986 Feb 01; 144(5):467-71. PubMed ID: 3956534
    [Abstract] [Full Text] [Related]

  • 55. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S, Wagemaker G, Souza LM, Tatarsky I.
    Leukemia; 1991 Apr 01; 5(4):340-6. PubMed ID: 1709245
    [Abstract] [Full Text] [Related]

  • 56. Vanadate mimics the effect of stem cell factor on highly purified human erythroid burst-forming units in vitro, but not the effect of erythropoietin.
    Dai CH, Krantz S.
    Exp Hematol; 1992 Oct 01; 20(9):1055-60. PubMed ID: 1281783
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells.
    Zauli G, Visani G, Vitale M, Gibellini D, Bertolaso L, Capitani S.
    Br J Haematol; 1995 Jun 01; 90(2):274-82. PubMed ID: 7540854
    [Abstract] [Full Text] [Related]

  • 59. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
    Tsujino Y, Wada H, Misawa M, Kai S, Hara H.
    Exp Hematol; 1993 Sep 01; 21(10):1379-86. PubMed ID: 7689484
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.